STE (STOCKS)
STERIS plc
$224.850000
+2.270000 (+1.02%)
Prev close: $222.580000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Daniel A. Carestio
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $22,050.21M
- Employees
- 17,787
- P/E (TTM)
- 31.11
- P/B (TTM)
- 3.08
- Dividend Yield
- 109.41%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q3)
|
$2.53 | $2.56 | -0.0278 | -1.09% |
|
Sep 2025 (Q2)
|
$2.47 | $2.37 | +0.0957 | +4.03% |
|
Jun 2025 (Q1)
|
$2.34 | $2.29 | +0.0539 | +2.36% |
|
Mar 2025 (Q4)
|
$2.74 | $2.62 | +0.1196 | +4.56% |
Financial Statements
| Revenues | $1.90B |
| Benefits Costs and Expenses | $875.40M |
| Cost Of Revenue | $1.10B |
| Cost Of Revenue, Goods | $589.19M |
| Cost Of Revenue, Services | $511.88M |
| Costs And Expenses | $875.40M |
| Gross Profit | $803.63M |
| Nonoperating Income/Loss | -$21.50M |
| Operating Expenses | $607.13M |
| Selling, General, and Administrative Expenses | $552.66M |
| Research and Development | $56.74M |
| Operating Income/Loss | $196.50M |
| Income/Loss Before Equity Method Investments | $175.00M |
| Income/Loss From Continuing Operations After Tax | $112.50M |
| Income/Loss From Continuing Operations Before Tax | $612.99M |
| Income Tax Expense/Benefit | $62.50M |
| Income Tax Expense/Benefit, Deferred | -$12.81M |
| Interest Expense, Operating | $23.16M |
| Net Income/Loss | $112.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $112.50M |
| Net Income/Loss Available To Common Stockholders, Basic | $112.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.88 |
| Diluted Earnings Per Share | $1.87 |
| Basic Average Shares | 119,380,000 |
| Diluted Average Shares | 120,526,000 |
| Assets | $2.31B |
| Current Assets | $713.01M |
| Inventory | $183.95M |
| Other Current Assets | $529.06M |
| Noncurrent Assets | $1.60B |
| Fixed Assets | $505.36M |
| Other Non-current Assets | $1.09B |
| Liabilities | $1.22B |
| Current Liabilities | $257.49M |
| Accounts Payable | $84.08M |
| Wages | $52.18M |
| Other Current Liabilities | $121.23M |
| Noncurrent Liabilities | $959.80M |
| Long-term Debt | $829.82M |
| Other Non-current Liabilities | $129.98M |
| Equity | $1.09B |
| Equity Attributable To Noncontrolling Interest | $826.00K |
| Equity Attributable To Parent | $1.09B |
| Liabilities And Equity | $2.31B |
| Net Cash Flow From Operating Activities | $220.60M |
| Net Cash Flow From Operating Activities, Continuing | $220.60M |
| Net Cash Flow From Investing Activities | -$329.39M |
| Net Cash Flow From Investing Activities, Continuing | -$329.39M |
| Net Cash Flow From Financing Activities | $140.54M |
| Net Cash Flow From Financing Activities, Continuing | $140.54M |
| Exchange Gains/Losses | -$16.99M |
| Net Cash Flow | $14.77M |
| Net Cash Flow, Continuing | $31.76M |
| Comprehensive Income/Loss | $119.71M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $100.11M |
| Other Comprehensive Income/Loss | $5.20M |
| Other Comprehensive Income/Loss Attributable To Parent | -$46.87M |